Menopausal and other perimenopausal disorders. Menopausal and other perimenopausal disorders
Conditions
Interventions
Intervention 1: Valerian 700 mg daily (two capsules 350 mg) one hour before bedtime for a period of 1 month. Intervention 2: placebo 700 mg daily (two capsules 350 mg starch) one hour before bedtime f
Treatment - Drugs
Placebo
Valerian 700 mg daily (two capsules 350 mg) one hour before bedtime for a period of 1 month
placebo 700 mg daily (two capsules 350 mg starch) one hour before bedtime for a period of 1 month
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
45 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Their age is between 60-45 years ; They have passed at least one year of amenorrhea ; Have a sleep disorder. More Pystbrg index equal to 5 ; not using Of drugs, tranquilizers, sleeping hormone replacement ; Do not have chronic systemic disease known to affect sleep ; Do not have mental illness ; have not consume Tobacco (cigarettes and shisha) and alcohol ; During a recent divorce, serious illness or death of family members is not really happening ; According to the research units having hot flashes Exclusion criteria: If the samples during the study of drugs, tranquilizers, sleeping or using hormone replacement ; If during the study divorce, serious illness or death of family members happened to be ; The use of tobacco (cigarettes or shisha) volatile during the research ; Iregular use of Valerian
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sleep quality. Timepoint: Before intervention, one month after the intervention, One month after the second intervention. Method of measurement: Questionnaire.;Hotflash. Timepoint: Before intervention, one month after the intervention, One month after the second intervention. Method of measurement: VAS.;Insomnia severity. Timepoint: Before intervention, one month after the intervention, One month after the second intervention. Method of measurement: Questionnaire.;Anxiety. Timepoint: Before intervention, one month after the intervention, One month after the second intervention. Method of measurement: Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effect of drug. Timepoint: Beginning of the study , after 1 month , end of the study. Method of measurement: by questionnaire Pittsburgh Sleep Quality Index. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactTahereh Zendedel
Tehran University of Medical Sciences
Outcome results
None listed